20/20 Biolabs, Inc.
$1.71
▼
-2.66%
2026-04-21 05:10:00
2020biolabs.com
NCM: AIDX
Explore 20/20 Biolabs, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
—
Current Price
$1.71
52W High / Low
$50 / $1.51
Stock P/E
—
Book Value
$0.01
Dividend Yield
—
ROCE
-253.94%
ROE
-5.03%
Face Value
—
EPS
$-0.36
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
—
Beta
—
Debt / Equity
0.56
Current Ratio
0.6
Quick Ratio
0.55
Forward P/E
—
Price / Sales
9.6
Enterprise Value
$20.01 M
EV / EBITDA
-6.17
EV / Revenue
9.79
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | HeartSciences Inc. | $2.05 | — | $6.85 M | — | -1607.2% | -3.82% | $6.47 / $1.89 | $0.83 |
| 2. | Lucid Diagnostics Inc. | $1.3 | — | $221.18 M | — | -418.44% | -7.11% | $1.7 / $0.95 | $-0.33 |
| 3. | Owlet, Inc. | $5.82 | — | $163.61 M | — | -19.96% | -8.02% | $16.94 / $3.08 | $0.71 |
| 4. | Stryker Corporation | $334.05 | 39.78 | $127.84 B | 1.04% | 12.63% | 15.08% | $404.87 / $319.32 | $58.61 |
| 5. | ENvue Medical, Inc. | $1.51 | — | $5.59 M | — | -394.93% | -30.51% | $75.48 / $0.99 | $42 |
| 6. | Biomerica, Inc. | $2.18 | — | $6.74 M | — | -122.16% | -84.3% | $4.6 / $1.87 | $1.5 |
| 7. | Co-Diagnostics, Inc. | $1.67 | — | $6.02 M | — | -147.54% | -1.26% | $46.5 / $1.35 | $9.85 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q4 2024 | |
|---|---|---|
| Sales | 0.54 M | 0.54 M |
| Operating Profit | -0.91 M | -1.24 M |
| Net Profit | -1.31 M | -1.25 M |
| EPS in Rs | -0.13 | -0.12 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 2.05 M | 1.75 M | 1.42 M |
| Operating Profit | -3.33 M | -5.66 M | -6.36 M |
| Net Profit | -3.74 M | -5.55 M | -6.39 M |
| EPS in Rs | -0.36 | -0.53 | -0.61 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 4.14 M | 3.58 M | 6.37 M |
| Total Liabilities | 4.16 M | 2.08 M | 2.08 M |
| Equity | -0.02 M | 1.51 M | 4.29 M |
| Current Assets | 1.47 M | 2.03 M | 4.3 M |
| Current Liabilities | 2.46 M | 1.36 M | 1.01 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | -1.92 M | -2.6 M | -4.48 M |
| Investing CF | — | 0 M | -0.04 M |
| Financing CF | 1.16 M | 0.29 M | -0.19 M |
| Free CF | -1.92 M | -2.6 M | -4.52 M |
| Capex | — | — | -0.04 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | 16.71% | 23.03% | — |
| Earnings Growth % | 32.65% | 13.14% | — |
| Profit Margin % | -182.82% | -316.81% | -448.73% |
| Operating Margin % | -162.87% | -323.06% | -446.64% |
| Gross Margin % | 29.56% | 20.56% | 7.66% |
| EBITDA Margin % | -171.36% | -308.35% | -435.03% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.